Vaccinum diphtheriae, tetani, pertussis sine cellulis ex elementis praeparatum, hepatitidis B (ADNr), poliomyelitidis inactivatum et haemophili stirpis b coniugatum adsorbatum

Medicinal product name Hexacima
Pharmaceutical form Suspension for injection
Strength  
Information from the MAH on shortages Not available
predicted availability date: not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code J07CA09 Vaccines

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: not notified
currently no information on availability from any wholesaler N1
(0,5 ml)
Glass pre-filled syringe with 2 needles 80.19  EU/1/13/828/006  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/13/828/006
Date of authorisation Apr 17, 2013
Marketing authorisation holder, country Sanofi Pasteur, France